Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $9.8 million.

  • Tandem Diabetes Care's Current Deferred Revenue fell 7687.41% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 7687.41%. This contributed to the annual value of $11.8 million for FY2024, which is 7310.77% down from last year.
  • As of Q3 2025, Tandem Diabetes Care's Current Deferred Revenue stood at $9.8 million, which was down 7687.41% from $10.5 million recorded in Q2 2025.
  • Tandem Diabetes Care's Current Deferred Revenue's 5-year high stood at $44.6 million during Q1 2024, with a 5-year trough of $6.7 million in Q1 2021.
  • For the 5-year period, Tandem Diabetes Care's Current Deferred Revenue averaged around $20.1 million, with its median value being $11.8 million (2024).
  • In the last 5 years, Tandem Diabetes Care's Current Deferred Revenue surged by 14364.11% in 2023 and then crashed by 7687.41% in 2025.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Current Deferred Revenue stood at $10.2 million in 2021, then surged by 85.0% to $18.8 million in 2022, then skyrocketed by 133.55% to $44.0 million in 2023, then crashed by 73.11% to $11.8 million in 2024, then decreased by 16.79% to $9.8 million in 2025.
  • Its Current Deferred Revenue stands at $9.8 million for Q3 2025, versus $10.5 million for Q2 2025 and $11.0 million for Q1 2025.